Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Ambit Biosciences Corporation (AMBI)

-NasdaqGM
5.70 0.26(4.78%) Jul 30, 4:00PM EDT
Prev Close:5.44
Open:5.46
Bid:5.17 x 300
Ask:N/A
1y Target Est:14.75
Beta:8.733
Next Earnings Date:12-Aug-14AMBI Earnings announcement
Day's Range:5.46 - 5.70
52wk Range:4.80 - 21.44
Volume:56,158
Avg Vol (3m):54,602
Market Cap:102.45M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AMBI

Comparison

Symbol% ChgMkt Cap
AMBIUp 4.78%102.45M
BAYRY112.18B
ONXXN/A
PFE186.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.29
Quarterly EPS Est (Jun-14) :-0.58
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ambit Biosciences Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback